SHARA MCPHALL: Open Payments
NPI 1003542549 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 52 payments from 12 companies in 2025. Trend: 2023 $2,468 · 2024 $1,629 · 2025 $1,488
Food & beverage: $1,488
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $496 |
| Janssen Pharmaceuticals, Inc | 7 | $381 |
| Otsuka America Pharmaceutical, Inc. | 7 | $204 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $106 |
| Vanda Pharmaceuticals Inc. | 5 | $88 |
| Teva Pharmaceuticals USA, Inc. | 2 | $62 |
| Collegium Pharmaceutical, Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, INVEGA SUSTENNA, REXULTI, CAPLYTA, UZEDY, FANAPT, Jornay PM, HETLIOZ.
Industry payments across FL — which companies pay providers there.
